MyUltimateBiz Work from Home

Theratechnologies Announces Financial Results and Closes the First Quarter in a Strong Financial Position
MONTREAL, CANADA–(Marketwire – 03/23/10) – Theratechnologies (TSX: TH – News ) — $57 M liquidity position and lower R&D expenses — New date set for FDA Advisory Committee meeting — Results from the second Phase 3 trial published in the medical journal JAIDS — Patents granted for tesamorelin in Brazil and Australia Theratechnologies (TSX: TH – News ) today announced its financial results for …

Read more on Marketwire via Yahoo! Finance